Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us dr. O.W. Akkerman

Research interests

Pharmacokinetics and pharmacodynamics of anti TB drugs

Inhalation of antimicrobial drugs

Holistic approach of TB care

Publications

A call to action on antimicrobial stewardship in tuberculosis: safeguarding effective tuberculosis treatment for future generations

Consensus on Management of Refractory Nontuberculous Mycobacterial Pulmonary Disease

Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function:: insights from a European multicenter survey

ERS Congress 2025:: highlights from the Respiratory Infections Assembly

Impact of isolation and hospitalisation for people with TB

Management of nontuberculous mycobacterial Pulmonary disease refractory to guideline-based therapy:: A systematic review

Physiological and Anatomical Alterations in Children with Liver Cirrhosis

Post-tuberculosis lung disease

Prioritizing research topics identified by end-users for a successful and rapid uptake of new tuberculosis treatment regimens

Rehabilitation for individuals with post-tuberculosis lung disease

Press/media

Tuberculose

Margaretha (31) had tuberculose, maar geen arts die dat voor mogelijk hield

Zweten is weten

Geen bloedtest, maar zweettest bij onderzoek naar inname tbc-medicatie

Zweettest die miljoenen tbc-patiënten wereldwijd kan helpen

Using Fingerprints to Detect Antibiotics

My congress 2024 video: Respiratory infections highlights

Aletta Talks. “Air pollution: out and inside”

Using a fingerprint for non-invasive drug monitoring

Sustainable Development Goals

SDG 2 - Zero HungerSDG 3 - Good Health and Well-beingSDG 5 - Gender EqualitySDG 8 - Decent Work and Economic GrowthSDG 10 - Reduced InequalitiesSDG 16 - Peace, Justice and Strong Institutions

More information about the Sustainable Development Goals.